World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

FREQUENCY OF FACTORS LEADING TO MULTI-DRUG RESISTANT TUBERCULOSIS

Dr. Imran Saeed*, Dr. Anum Mushtaq Khan, Dr. Sadia Naz

ABSTRACT

Objective: The objective of this study is “to determine the frequency of factors leading to Multidrug resistance tuberculosis, in patients presenting at Nishtar Medical University and Hospital Multan”. Material and methods: This cross sectional was conducting at Department of Pulmonology, Nishtar Medical University and Hospital Multan from March 2019 to September 2019. Total 126 patients with MDR-TB were selected for this study. Association of reasons for interruption of ATT course, inadequate chemotherapy, under whose prescription ATT used previously and Previous H/O of taking ATT with gender, age and area of residence was assessed. Results: Total 126 patients with MDR-TB were included in this study. Minimum age of the patients was 20 years and maximum age of the patients was 60 years. Mean age of the patients was 39.44 ± 9.043. Most 65 (51.6%) of the patients with MDR-TB belonged to age group 31-40 years and 74 (58.7%) were male and 52 (41.3%) were female. Conclusion: Results of this study revealed that the most common age group affected with MDR-TB was 31-40 years. Male were more victim as compare to female. Mostly patients reported with MDR-TB have previous history of taking ATT under.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR